Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Jun;18(2):138-43.
doi: 10.5223/pghn.2015.18.2.138. Epub 2015 Jun 29.

Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly

Jung Ah Kim  1 , Ja Hye Kim  1 , Beom Hee Lee  1 , Gu-Hwan Kim  2 , Yoon S Shin  3 , Han-Wook Yoo  1 , Kyung Mo Kim  1
Affiliations
Case Reports

Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly

Jung Ah Kim et al. Pediatr Gastroenterol Hepatol Nutr. 2015 Jun.

Abstract

Glycogen storage disease type IX (GSD IX) is caused by a defect in phosphorylase b kinase (PhK) that results from mutations in the PHKA2, PHKB, and PHKG2 genes. Patients usually manifest recurrent ketotic hypoglycemia with growth delay, but some may present simple hepatomegaly. Although GSD IX is one of the most common causes of GSDs, its biochemical and genetic diagnosis has been problematic due to its rarity, phenotypic overlap with other types of GSDs, and genetic heterogeneities. In our report, a 22-month-old boy with GSD IX is described. No other manifestations were evident except for hepatomegaly. His growth and development also have been proceeding normally. Diagnosed was made by histologic examination, an enzyme assay, and genetic testing with known c.3210_3212del (p.Arg1070del) mutation in PHKA2 gene.

Keywords: Glycogen storage disease; Glycogen storage disease type IX; Hepatomegaly; Phosphorylase b kinase 2; Phosphorylase kinase.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Pathologic findings. (A) Hepatocytes were filled with abundant glycogen particles in the cytoplasmonroutine transmission electron microscopy (×200). (B) Hepatocyte cytoplasmic material was positive byperiodic acid-Schiff staining (×200). (C) Hepatocyte cytoplasmic material was digested by diastase-treatment (×200).
Fig. 2
Fig. 2. Partial genomic sequences of the PHAK2 gene. (A) The patient is a homozygotefor the c.3210_3212del (p.Arg1070del) mutation. (B) His mother is a heterozygote for this mutation.
See this image and copyright information in PMC

References

    1. Lau CK, Hui J, Fong FN, To KF, Fok TF, Tang NL, et al. Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China. Mol Genet Metab. 2011;102:222–225. - PubMed
    1. Maichele AJ, Burwinkel B, Maire I, Søvik O, Kilimann MW. Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans. Nat Genet. 1996;14:337–340. - PubMed
    1. Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol. 1989;24:69–99. - PubMed
    1. Tsilianidis LA, Fiske LM, Siegel S, Lumpkin C, Hoyt K, Wasserstein M, et al. Aggressive therapy improves cirrhosis in glycogen storage disease type IX. Mol Genet Metab. 2013;109:179–182. - PMC - PubMed
    1. Bali DS, Goldstein JL, Fredrickson K, Rehder C, Boney A, Austin S, et al. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol Genet Metab. 2014;111:309–313. - PMC - PubMed

Publication types